Therapix Biosciences Ltd.

Therapix Biosciences Ltd. (NASDAQ:TRPX)
NASDAQ Ticker Symbol: TRPX
Frankfurt Ticker Symbol: 4TXA

Therapix Biosciences Ltd. (NASDAQ:TRPX) (FRA:4TXA) is a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs. With this focus, Therapix has initiated two internal drug development programs based on repurposing a U.S. Food and Drug Administration approved synthetic cannabinoid (dronabinol). These two developments include: Joint Pharma developing THX-TS01 targeted to the treatment of Tourette Syndrome, and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of mild cognitive impairments.

ZIP Code: 5320047
Business Website Address:
Business Phone Number: +972โ€“3-6167055
Business Fax: +972โ€“3-6167056
Country: Israel